October 19, 2016
FDA approves Roche’s cancer immunotherapy Tecentriq for metastatic NSCLC
FDA approves Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Sandra Horning